Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oocyte-expressed protein homolog (OOEP) is a cytoplasmic and nuclear protein involved in oocyte maturation and early embryonic development. It is a key component of the subcortical maternal complex (SCMC), which is essential for the first divisions after fertilization. OOEP promotes RNA binding, regulates actin cytoskeleton dynamics critical for mitotic spindle formation and placement, and actively supports the homologous recombination-mediated DNA double-strand break repair pathway in oocytes. It is vital for oocyte survival, meiotic resumption, and symmetric zygotic division. Variants in OOEP are associated with developmental disorders including Temple syndrome and gestational trophoblastic neoplasm.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oocyte-expressed protein homolog (OOEP).